When Fewer Grants Get Funded, Translation Becomes the Deciding Factor

I have been watching the numbers, and I know you have too.

R01 success rates dropped from roughly 27% to 20% for established investigators in fiscal year 2025. At the National Cancer Institute, the odds fell even further — from one in ten to one in twenty-five. Multiple institutes have stopped publishing fixed paylines altogether, and a new multiyear funding policy is consuming budget that would have gone to new awards. The total number of investigators winning R01-equivalent grants fell from 7,720 in 2024 to 5,885 in 2025 — nearly 2,000 fewer funded scientists in a single year.

I am not writing this to add to your anxiety. You already feel it. I am writing this because the funding climate has changed what it takes to get funded, and that change is not about your science. It is about your translation.

Here is what I mean.

When paylines were at the 20th percentile, a grant that scored a 30 had a reasonable shot. The science was strong, the approach was sound, the reviewer saw the value even if the writing was imperfect. Room existed in the system for applications that were good enough.

That room is shrinking. When an institute funds at the 10th percentile — or eliminates paylines entirely and funds "based on scientific merit, program priorities, portfolio balance, and availability of funds" — only the grants that reviewers fight hardest for survive the discussion.

And that fight happens in a room you will never enter.

After individual scoring, the reviewers assigned to your application stand up in the study section and make the case for your work. They summarize your project. They argue for its importance. They defend your approach against critiques from reviewers who may not have read the full application.

The question is: did you give them the words to do that?

This is what I call Translation Gap 5 — the gap between your vision and the reviewer's advocacy. It is always important. But when funding gets harder, it becomes the gap that decides everything.

A grant that scored a 25 in a flush year might have been funded without much discussion. In a constrained year, that same 25 goes to discussion, and the reviewer has to convince the room. If they cannot articulate — in two sentences — why your work matters more than the other grants competing for the same shrinking pool, your score drifts upward. A 25 becomes a 30 becomes unfunded.

The science did not change. The translation failed.

I built the Lost in Translation curriculum on the premise that most grants fail not because the science is weak, but because the meaning gets lost between the researcher's mind and the reviewer's understanding. That premise was true when success rates were 25%. It is more consequential now.

Here is what tighter funding means for your writing, practically:

Your opening paragraph has less margin for error. When a reviewer is reading twelve applications instead of eight, the first three sentences determine whether they engage or move on. A generic opening — "It is well established that..." or "There is a critical need for..." — is no longer just weak writing. It is a competitive liability. In a field where every scored point matters, the thirty seconds a reviewer spends on your opening paragraph may be the most important thirty seconds in your funding trajectory.

Your impact statement must be borrowable. The reviewer who advocates for your grant in discussion does not have time to construct a new argument on the spot. They borrow yours. If your impact statement is "this study will advance knowledge in the field," they have nothing to borrow. If your impact statement gives them a specific, memorable claim — a number, a population, a consequence — they can argue for you effectively. In a constrained funding environment, borrowable language is not a nice-to-have. It is infrastructure.

Your confidence must be earned, not performed. When fewer grants get funded, reviewers become more skeptical of overclaiming and more sensitive to hedging. Both are trust failures. "This novel and innovative approach" tells the reviewer nothing. "This is the first community-based intervention with verified effectiveness for lung cancer screening among Black adults" tells the reviewer something specific and verifiable. The difference between these two sentences is not style. It is the difference between a claim a reviewer will repeat and a claim they will discount.

None of this requires you to change your science. It requires you to close the distance between what you understand about your work and what a reviewer can communicate about it to others in a room you will never enter.

That distance — the translation gap — has always been where grants succeed or fail. What has changed is that the margin for translation failure is narrower than it has ever been.

If you are writing a grant right now, or preparing to resubmit one, I would encourage you to try something before you touch your draft again. Sit down with someone you trust — a colleague, a friend, someone outside your field — and explain your research as if you were having a conversation over coffee. No jargon. No grant language. Just: what is the problem, what are you going to do about it, and why will it matter.

Then read your grant draft. Listen for where the coffee conversation version is clearer than the written version. Those are your translation gaps. And in this funding environment, closing them is not optional.

Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM

Creator, Lost in Translation Grantsmanship Curriculum | Soul to Soul Leadership LLC

© 2026

Not sure where your grant is losing reviewers? Take the free Grant Translation Diagnostic — it takes about 10 minutes.

Ready to go deeper? Start Module 1 for free →